NF-kappaB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection

Free Radic Biol Med. 2001 Aug 1;31(3):355-66. doi: 10.1016/s0891-5849(01)00592-5.

Abstract

Oxygen radicals are considered as an important regulator in the pathogenesis of Helicobacter pylori (H. pylori)-induced gastric ulceration and carcinogenesis. Inflammatory genes including inducible nitric oxide synthase (iNOS) may be regulated by oxidant-sensitive transcription factor, nuclear factor-kappaB (NF-kappaB). iNOS induction has been related to gastric apoptosis. We studied the role of NF-kappaB on iNOS expression and apoptosis in H. pylori-stimulated gastric epithelial AGS cells. AGS cells were treated with antisense oligonucleotide (AS ODN) for NF-kappaB subunit p50, an antioxidant enzyme catalase, an inhibitor of NF-kappaB activation pyrrolidine dithiocarbamate (PDTC), iNOS inhibitors N(G)-nitro-L-arginine-methyl ester (L-NAME) and 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT), a peroxynitrite donor SIN-1, and a nitric oxide donor NOC-18 in the presence or absence of H. pylori. H. pylori induced cytotocixity time- and dose-dependently, which occurred with induction in iNOS expression and nitrite production. SIN-1 and NOC-18 induced dose-dependent cytotoxicity in AGS cells. Catalase, PDTC, L-NAME, and AMT prevented H. pylori-induced cytotoxicity and apoptosis. It was related to their inhibition on iNOS expression and nitrite production. The cells treated with AS ODN had low levels of p50 and NF-kappaB and inhibited H. pylori-induced cytotoxicity, apoptosis, iNOS expression, and nitrite production. In conclusion, NF-kappaB plays a novel role in iNOS expression and apoptosis in H. pylori-infected gastric epithelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Apoptosis*
  • Catalase / pharmacology
  • Cell Line
  • Cell Survival / drug effects
  • Enzyme Induction
  • Gastric Mucosa / cytology
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / microbiology*
  • Gastric Mucosa / physiology
  • Gene Expression Regulation, Enzymologic*
  • Helicobacter Infections / genetics
  • Helicobacter Infections / pathology
  • Helicobacter Infections / physiopathology*
  • Helicobacter pylori*
  • Humans
  • Molsidomine / analogs & derivatives
  • Molsidomine / pharmacology
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / biosynthesis
  • Nitric Oxide Synthase / genetics*
  • Nitric Oxide Synthase Type II
  • Nitroso Compounds / pharmacology
  • Oligodeoxyribonucleotides, Antisense / pharmacology
  • Pyrrolidines / pharmacology
  • Radiation-Protective Agents / pharmacology
  • Thiazines / pharmacology
  • Thiocarbamates / pharmacology

Substances

  • Antioxidants
  • NF-kappa B
  • NOC 18
  • Nitric Oxide Donors
  • Nitroso Compounds
  • Oligodeoxyribonucleotides, Antisense
  • Pyrrolidines
  • Radiation-Protective Agents
  • Thiazines
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid
  • 2-amino-5,6-dihydro-4H-1,3-thiazine
  • linsidomine
  • Molsidomine
  • Catalase
  • NOS2 protein, human
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • NG-Nitroarginine Methyl Ester